News » MHRA alert » Atomoxetine capsules recall
June 6th 2024
Neuraxpharm UK Ltd is recalling selected batches of atomoxetine 10mg, 18mg, 25mg and 40mg capsules.
The affected batches are:
Atomoxetine 10mg capsules:
|
Batch Number |
Expiry Date |
Pack Size |
First Distributed |
|
1211145 |
09/2025 |
7 |
23/02/2023 |
|
1203816 |
03/2025 |
7 |
07/07/2022 |
Atomoxetine 18mg capsules:
|
Batch Number |
Expiry Date |
Pack Size |
First Distributed |
|
1211146 |
09/2025 |
7 |
23/02/2023 |
Atomoxetine 25mg capsules:
|
Batch Number |
Expiry Date |
Pack Size |
First Distributed |
|
1211147 |
06/2025 |
7 |
23/02/2023 |
|
1207940 |
06/2025 |
7 |
24/10/2022 |
Atomoxetine 40mg capsules:
|
Batch Number |
Expiry Date |
Pack Size |
First Distributed |
|
1211148 |
09/2025 |
7 |
23/02/2023 |
|
1203818 |
03/2025 |
7 |
07/07/2022 |
The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.
Healthcare teams are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process. Patients should continue to take medicines from these batches as prescribed.
For medical information enquiries please contact medinfo-uk@neuraxpharm.com or telephone +44 (0) 118 211 4039
For stock control enquiries please contact info-uk@neuraxpharm.com or telephone +44 (0) 118 211 4039
